Cite
HARVARD Citation
van den Broek, M. et al. (2022). Critical appraisal of evidence for anti-Xa monitoring and dosing of low-molecular-weight heparin in renal insufficiency. Expert review of clinical pharmacology. 15 (10), pp. 1155-1163. [Online].